-
Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.
J Virol. 2000 May;74(10):4795-806
PMID: 10775618
-
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.
J Virol. 1998 Apr;72(4):2855-64
PMID: 9525605
-
Complementation between HIV integrase proteins mutated in different domains.
EMBO J. 1993 Aug;12(8):3261-7
PMID: 8344263
-
Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.
J Virol. 2001 Dec;75(23):11365-72
PMID: 11689617
-
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
J Virol. 1992 Apr;66(4):2232-9
PMID: 1548759
-
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
J Virol. 1986 Aug;59(2):284-91
PMID: 3016298
-
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
J Virol. 1995 Jun;69(6):3389-98
PMID: 7745685
-
Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
J Virol. 1995 Nov;69(11):6687-96
PMID: 7474078
-
Mutations in nonconserved domains of Ty3 integrase affect multiple stages of the Ty3 life cycle.
J Virol. 1999 Jan;73(1):453-65
PMID: 9847351
-
Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.
J Virol. 1996 Feb;70(2):721-8
PMID: 8551608
-
Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.
J Virol. 1999 Mar;73(3):2126-35
PMID: 9971795
-
Construction and analysis of deletion mutations in the pol gene of Moloney murine leukemia virus: a new viral function required for productive infection.
Cell. 1984 Jul;37(3):1043-52
PMID: 6204767
-
HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other.
FEBS Lett. 2001 Oct 19;507(1):39-44
PMID: 11682056
-
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes.
Virology. 1993 Jun;194(2):858-64
PMID: 8503191
-
Production of trans-lentiviral vector with predictable safety.
Methods Mol Med. 2003;76:449-65
PMID: 12526179
-
Ty3 integrase is required for initiation of reverse transcription.
J Virol. 2002 Mar;76(6):2804-16
PMID: 11861848
-
Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
Virology. 1996 May 1;219(1):29-36
PMID: 8623542
-
Monoclonal antibodies against the minimal DNA-binding domain in the carboxyl-terminal region of human immunodeficiency virus type 1 integrase.
J Virol. 1999 May;73(5):4475-80
PMID: 10196350
-
Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1.
J Virol. 1999 Oct;73(10):8831-6
PMID: 10482639
-
Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.
Nat Med. 2001 Aug;7(8):920-6
PMID: 11479624
-
Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases.
Biochem J. 2002 Feb 1;361(Pt 3):557-66
PMID: 11802785
-
Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting.
J Virol. 1990 Oct;64(10):4709-17
PMID: 2204722
-
Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication.
J Virol. 1996 Jan;70(1):651-7
PMID: 8523588
-
Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
EMBO J. 1997 Aug 15;16(16):5113-22
PMID: 9305652
-
Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein.
J Virol. 1991 Apr;65(4):2141-5
PMID: 2002557
-
PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.
Nucleic Acids Res. 1997 Jul 15;25(14):2745-51
PMID: 9207020
-
The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
J Virol. 2002 May;76(9):4331-40
PMID: 11932399
-
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
Cell. 1990 Apr 20;61(2):213-22
PMID: 2331748
-
Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase.
J Virol. 1997 May;71(5):3507-14
PMID: 9094622
-
Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection.
J Virol. 1996 Jun;70(6):3870-5
PMID: 8648723
-
Genetic analysis of the human immunodeficiency virus type 1 integrase protein.
J Virol. 1994 Mar;68(3):1633-42
PMID: 8107224
-
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
J Virol. 1993 Aug;67(8):4945-55
PMID: 8331734
-
Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
J Virol. 1995 May;69(5):2729-36
PMID: 7535863
-
Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli.
J Virol. 1986 Oct;60(1):267-74
PMID: 2427747
-
Analysis of human immunodeficiency virus type 1 integrase mutants.
Virology. 1995 Aug 1;211(1):332-5
PMID: 7544046
-
Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease.
J Virol. 1996 Oct;70(10):6820-5
PMID: 8794322
-
Base-calling of automated sequencer traces using phred. I. Accuracy assessment.
Genome Res. 1998 Mar;8(3):175-85
PMID: 9521921
-
Ribbons.
Methods Enzymol. 1997;277:493-505
PMID: 18488321
-
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.
Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905
PMID: 12019106